Search for: "Human Genome Sciences Inc. "
Results 41 - 60
of 125
Sorted by Relevance
|
Sort by Date
19 Jul 2011, 4:39 am
The United Kingdom's Supreme Court is currently hearing the appeal in an important patent case, Human Genome Sciences Inc v Eli Lilly and Company UKSC 2010/0047. [read post]
16 Nov 2010, 6:13 pm
WaferGen Biosystems Inc and Generex Biotechnology Corp have received grants from the IRS and the Department of Health and Human Services under the Qualifying Therapeutic Discovery Project program established under Section 48D of the Internal Revenue Code. [read post]
19 Feb 2016, 1:00 am
If you’re practising in this field and want to know more, the IPKat suggests you quench your thirst from the source, which is Regeneron Pharmaceuticals Inc v Kymab Ltd & Anor [2016] EWHC 87 (Pat).The invention relates to modifying a mouse genome by swapping out specific segments and replacing them with a human gene segments. [read post]
21 Mar 2012, 9:56 am
Joseph “Chip” Skowron III, a former manager at hedge fund FrontPoint Partners, admitted last year that he directed several FrontPoint healthcare funds to dump shares in biotechnology company Human Genome Sciences Inc. in 2008 based on inside information he obtained about clinical drug trials from a French doctor. [read post]
10 Feb 2010, 4:47 pm
- UK: EWCA dismisses Human Genome Sciences appeal against decision finding invalidity; invention not ‘susceptible of industrial application’: Eli Lilly v Human Genome Sciences Inc (EPLAW) (IPKat) Nuvigil (Armodafinil) – US: Patent infringement complaints filed in Colorado and Delaware following a Paragraph IV certification as part of Sandoz's filing of an ANDA to manufacture a generic version of Cephalon's… [read post]
25 Jul 2011, 1:07 am
will be decided this week, this time by the European Patent Office in Human Genome Sciences Inc v Eli Lilly and Company [2010] EWCA Civ 33. [read post]
20 May 2010, 2:27 pm
Funding for this research came from Synthetic Genomics Inc., a company co-founded by Drs. [read post]
2 Nov 2011, 11:56 pm
Human Genome Sciences Inc (Appellant) v Eli Lilly and Company (Respondent) [see judgment, press summary, BAILII] In holding that gene sequences can have industrial application, reversing the lower courts’ findings, the Supreme Court gave primacy two policy arguments- attracting biosciences investment into the UK and bringing UK interpretations in compliance with the European Patent Convention. [read post]
9 Feb 2010, 3:52 am
Court of Appeal (Criminal Division) Curtis v R [2010] EWCA Crim 123 (09 February 2010) Court of Appeal (Civil Division) O’Beirne v Hudson [2010] EWCA Civ 52 (09 February 2010) Drew v Whitbread [2010] EWCA Civ 53 (09 February 2010) B, R (on the application of) v Cornwall Council & Anor [2010] EWCA Civ 55 (09 February 2010) W (Children), Re [2010] EWCA Civ 57 (09 February 2010) Eli Lilly & Co v Human Genome Sciences Inc [2010] EWCA Civ 33 (09 February… [read post]
2 Nov 2011, 11:56 pm
Human Genome Sciences Inc (Appellant) v Eli Lilly and Company (Respondent) [see judgment, press summary, BAILII] In holding that gene sequences can have industrial application, reversing the lower courts’ findings, the Supreme Court gave primacy two policy arguments- attracting biosciences investment into the UK and bringing UK interpretations in compliance with the European Patent Convention. [read post]
14 Apr 2011, 6:02 am
“Chip” Skowron, a former portfolio manager for six health care-related hedge funds affiliated with FrontPoint Partners LLC, sold hedge fund holdings of Human Genome Sciences Inc. [read post]
29 Jul 2018, 1:48 pm
Furry Babies Stratford Square, Inc., No. 13-3592, slip op. at 9 (Ill. 18th Jud. [read post]
12 Dec 2013, 7:12 am
In short, where the patent holder has already obtained an SPC on the basis of a patent protecting an innovative active ingredient and a marketing authorisation for a medicinal product containing that ingredient as the single active ingredient, and that SPC entitles him to oppose the use of that active ingredient, either alone or in combination with other active ingredients, Article 3(c) of the SPC Regulation must be interpreted as precluding that patent holder from obtaining –- on the basis of… [read post]
1 Jan 2019, 9:05 pm
CLARITY-BPA was designed by the National Institute of Environmental Health Sciences (NIEHS), National Toxicology Program (NTP) and U.S. [read post]
1 Oct 2008, 12:00 pm
It has been revised to take into account, among other things, recent case law including the House of Lords judgment in Angiotech (IPKat commentary here) and the Patents Court judgments in Eli Lilly & Co. v Human Genome Sciences, Inc. [read post]
19 Jun 2013, 6:12 am
” In a case that has profound implications for the life sciences industry, the Court ruled last week that complementary DNA (cDNA), derived of human intervention, is patent eligible subject matter; but that unaltered DNA, merely by its isolation from the human genome, is not patent eligible. [read post]
15 Dec 2011, 9:00 am
"Human Genome Sciences Inc., et. al. v. [read post]
18 Nov 2010, 7:21 am
The federal government’s focus on insider trading and hedge funds continues, with the recent filing of a criminal complaint and SEC enforcement action against a French medical doctor, who served on a steering committee overseeing a clinical trial of a drug under development by Human Genome Sciences, Inc. [read post]
23 Jul 2012, 12:00 am
Myriad Genetics, Inc. [read post]
13 Apr 2011, 8:57 am
In parallel criminal and civil complaints, prosecutors and regulators alleged that in late 2007 and early 2008 his tips to an unnamed portfolio manager enabled the manager’s hedge-fund to avoid $30 million of losses by selling shares in Human Genome Sciences Inc. ahead of negative news about the company’s trial of a drug for hepatitis C, the liver disease. [read post]
